Misonix Reports FYE 2006 Q3 Results
8th May 2006, 21:58 GMT
Misonix, a developer of ultrasonic medical device technology for the treatment of cancer and other health conditions, announced the results of the Company's fiscal Q3 and 9 months ended 3/31/2006.
Misonix Reports FYE 2006 Q3 Results related news:
- NMHC Reports Q3 FYE 2006 Results — StratWire - Business of Healthcare NewsFeed
- LightPath Technologies Announces Q3 FYE 2006 Financial Results — Operations-Related News from StratCenter.com
- Aastrom Biosciences Reports Q3 FYE 2006 Financial Results — StratWire - Business of Healthcare NewsFeed
- Bioniche Reports Q3 Results for FYE 2006 — Bio-Technology News from StratCenter.com
- Implant Sciences Announces 129% Increase in FYE 2006 Q3 Revenues — Financial News News from StratCenter.com
- Mentor Announces Webcast of Q4 and FYE Financial Results for FYE 2006 — Operations-Related News from StratCenter.com
- PolyMedica to Broadcast FYE 2006 Q4 and FYE Results — StratWire - Business of Healthcare NewsFeed
- Neurobiological Technologies Reports Q3 Results — Partnerships/ Joint Ventures News from StratCenter.com
- TLCVision Reports Q1 2006 Financial Results; On Target With Refractive Expansion Strategy and Reaffirms FYE Outlook — StratWire - Business of Healthcare NewsFeed
- Cholestech Announces Q4 and FYE 2006 Results — StratWire - Business of Healthcare NewsFeed
Latest news from Obstetrics/ Gynecology News from StratCenter.com:
- Acusphere Reports Q3 2006 Financial Results and Accomplishments
- CuraGen and TopoTarget Announce Initiation of NCI-Sponsored Phase II Trial of PXD101 for Ovarian Cancer
- Twin Cities Takes Action to Save Babies
- Substantial Regression of Atherosclerosis May Help Improve Diseased Arteries
- EDAP TMS SA to Participate in Int'l Urology Conferences
- Misonix Showcases SonicOne Ultrasonic Wound Debrider with Medline at MEDICA 2006 in Germany
- 8 Studies Evaluating Cytyc's Novasure System Presented at AAGL Meeting